Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Investor Alert: Lawsuit Alleges False and Misleading Statements
An investor, who purchased shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT), filed a lawsuit in the U.S. District Court for the Southern District of New York, over alleged violations of Federal Securities Laws by Intercept Pharmaceuticals Inc in connection with certain allegedly false and misleading statements made between January 9, 2014 and January 10, 2014
View full press release